Description  Claims  Cited references 

US2009024756A1   [0003] 
US4115538A   [0021] 
US5436128A   [0022] 
US6136839A   [0055] 

J. Biol. Chem.   [0019] 
J. Biol. Chem.   [0020] 
J. Biol. Chem.   [0021] 
Am. J. Resp. Cell and Mol. Biol.   [0021] 
Nature Biotechnology   [0022] 
Remington's Pharmaceutical Sciences   [0025] 
Remington: The Science and Practice of Pharmacy   [0029]  [0032]  [0036]  [0038]  [0041] 
Remington's Pharmaceutical Sciences   [0041] 
Remington's Pharmaceutical Sciences   [0042] 
Pro-drugs as Novel Delivery Systems   [0048] 
Bioreversible Carriers in Drug Design   [0048] 
Analgesic-Antipyretic and Anti-inflammatory Agents and Drugs Employed in the Treatment of Gout   [0054] 
Analgesic, Antipyretic and Anti-Inflammatory Drugs   [0054] 
Remington's Pharmaceutical Sciences   [0080] 
Adv. Enzyme Regul.   [0086] 
Chem. Ber.   [0107] 
JPET   [0151] 
The utility of the cold pain test to measure analgesia from intravenous morphine   [0159] 
Pain Models in Healthy Volunteers   [0159] 
Analgesic Efficacy of Controlled-Release DihydroCodeine   [0159] 
The effect of lamotrigine (300 mg) and dipipanone (4 mg and 8 mg), alone and in combination, on the cold-pain test in healthy volunteers   [0159]